Although POLE exonuclease domain mutations have been reported to have a benign effect on prognosis in patients with endometrial cancer, little is known about the relationship and possible mechanism between the POLE mutational status and endometrial cancer patient prognosis. Here, POLE is linked to endometrial cancer.